In this article, Roche discusses the increasing automation of science and next-generation sequencing (NGS) in particular and demonstrates an efficient DNA hybridization workflow.
In this article, Roche demonstrates how their KAPA HyperPETE workflow can provide improved targeted next-generation sequencing (NGS), and thereby provide strong therapeutic prospects for cancerresearch.